Alagille Syndrome (ALGS) is a rare genetic disorder that primarily affects the liver, heart, and other organ systems due to a paucity of bile ducts. Characterized by severe cholestatic pruritus (intense itching), jaundice, and potential liver failure, the market for ALGS therapeutics has transitioned from purely symptomatic management to targeted pharmacological interventions. https://www.databridgemarketresearch.com/reports/global-alagille-syndrome-market